Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Immunosurveillance in clinical cancer management
Guido Kroemer, Timothy A. Chan, Alexander M.M. Eggermont, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 187-202
Open Access | Times Cited: 62
Immunogenicity of ferroptosis in cancer: a matter of context?
Elena Catanzaro, Robin Demuynck, Faye Naessens, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 407-416
Closed Access | Times Cited: 16
A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects
Guanghui An, Heming Zheng, Lianshan Guo, et al.
Journal of Colloid and Interface Science (2024) Vol. 662, pp. 298-312
Closed Access | Times Cited: 14
Emerging role of immunogenic cell death in cancer immunotherapy
Kei‐ichiro Arimoto, Sayuri Miyauchi, Mengdan Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 12
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma
Giulio Cassanello, Alejandro Luna, Lorenzo Falchi
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy
Lingzhi Wang, Shengnan Bi, Zhuo Li, et al.
Biomaterials (2024) Vol. 313, pp. 122766-122766
Closed Access | Times Cited: 8
HMGB2-induced calreticulin translocation required for immunogenic cell death and ferroptosis of cancer cells are controlled by the nuclear exporter XPO1
jingqi Fan, Kevin P. Gillespie, Clementina Mesaros, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
Targeting acid ceramidase enhances antitumor immune response in colorectal cancer
Yadu Vijayan, Shirley James, Viswanathan Arun, et al.
Journal of Advanced Research (2023) Vol. 65, pp. 73-87
Open Access | Times Cited: 12
Immunogenic cell stress and death in the treatment of cancer
Hui Pan, Peng Liu, Liwei Zhao, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 156, pp. 11-21
Open Access | Times Cited: 11
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 4
The Role of Therapeutic Vaccines in Cancer Immunotherapy
Constantin N. Baxevanis, Ourania E. Tsitsilonis, Maria Goulielmaki, et al.
Onco (2025) Vol. 5, Iss. 1, pp. 11-11
Open Access
Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death
D. H. Zhang, Songze Song, Jing Lin, et al.
Developmental Cell (2025)
Closed Access
Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer (NSCLC): A prognostic clinical and biomarker-based model
Rianne D.W. Vaes, Francesco Cortiula, Shaowen Lyu, et al.
Lung Cancer (2025), pp. 108541-108541
Open Access
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 2: implementation strategies
W. Land, Andreas Linkermann
Frontiers in Transplantation (2025) Vol. 4
Open Access
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 1: their emergence from injuries to the donor organ
W. Land, Andreas Linkermann
Frontiers in Transplantation (2025) Vol. 4
Open Access
Chemoimmunotherapy combinations: translating basic knowledge into clinical successes
Lionel Apétoh
Genes and Immunity (2024) Vol. 25, Iss. 2, pp. 99-101
Open Access | Times Cited: 3
Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death
Wang Liu, Chenchen He, Changlin Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 9
Dendritic Cells Pulsed with Tumor Lysates Induced by Tetracyanotetra(aryl)porphyrazines-Based Photodynamic Therapy Effectively Trigger Anti-Tumor Immunity in an Orthotopic Mouse Glioma Model
Tikhon S. Redkin, Ekaterina E. Sleptsova, Victoria D. Turubanova, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2430-2430
Open Access | Times Cited: 8
Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy
Nayeon Shim, Hanhee Cho, Seong Ik Jeon, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 54, Iss. 1, pp. 13-36
Closed Access | Times Cited: 7
Decreased Lung Metastasis in Triple Negative Breast Cancer Following Locally Delivered Supratherapeutic Paclitaxel-Loaded Polyglycerol Carbonate Nanoparticle Therapy
Robert C. Sabatelle, Ngoc-Quynh Chu, William A. Blessing, et al.
Biomacromolecules (2024) Vol. 25, Iss. 3, pp. 1800-1809
Closed Access | Times Cited: 2
Nanoparticles Integrated with Mild Photothermal Therapy and Oxaliplatin for Tumor cHemotherapy and Immunotherapy
Qiong Yi, Shumin He, Kai Liao, et al.
Nanomedicine (2024) Vol. 19, Iss. 10, pp. 841-854
Closed Access | Times Cited: 2
Trial watch: local anesthetics in cancer therapy
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Nanostructure-reinforced multifunctional hydrogels for synergistic cancer therapy
Satar Yousefiasl, Mahsa Ghovvati, Mojdeh Mirshafiei, et al.
Coordination Chemistry Reviews (2024) Vol. 522, pp. 216207-216207
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top